Daiwa Securities Group Inc. Puma Biotechnology, Inc. Transaction History

Daiwa Securities Group Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 04, 2021	SELL	$7.78 - $12.13 $1,213 - $1,892	-156 Reduced 64.2%	87 $1,000
Q1 2019 Apr 26, 2019	BUY	$20.77 - $42.37 $747 - $1,525	36 Added 17.39%	243 $9,000
Q2 2018 Jul 30, 2018	SELL	$48.3 - $68.25 $1.04 Million - $1.47 Million	-21,487 Reduced 99.05%	207 $12,000
Q1 2018 May 02, 2018	BUY	$59.7 - $99.25 $116,415 - $193,537	1,950 Added 9.88%	21,694 $1.48 Million
Q4 2017 Feb 06, 2018	BUY	$93.85 - $132.45 $1.85 Million - $2.62 Million	19,744	19,744 $1.95 Million

110

28.3M

27.9K

3.4K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $155M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.